BRPI0710550A2 - uso de uma dose imunogênica de material imunogênico de mycoplasma hyopneumoniae e uma dose imunogênica de vìrus de prrs atenuado vivo, kit de vacina, e, método para a vacinação de porcos - Google Patents
uso de uma dose imunogênica de material imunogênico de mycoplasma hyopneumoniae e uma dose imunogênica de vìrus de prrs atenuado vivo, kit de vacina, e, método para a vacinação de porcos Download PDFInfo
- Publication number
- BRPI0710550A2 BRPI0710550A2 BRPI0710550-9A BRPI0710550A BRPI0710550A2 BR PI0710550 A2 BRPI0710550 A2 BR PI0710550A2 BR PI0710550 A BRPI0710550 A BR PI0710550A BR PI0710550 A2 BRPI0710550 A2 BR PI0710550A2
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- mycoplasma hyopneumoniae
- immunogenic
- virus
- vaccination
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract description 91
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 title claims abstract description 72
- 241000700605 Viruses Species 0.000 title claims abstract description 45
- 230000002163 immunogen Effects 0.000 title claims abstract description 45
- 230000002238 attenuated effect Effects 0.000 title claims abstract description 25
- 239000000463 material Substances 0.000 title claims abstract description 23
- 241000282887 Suidae Species 0.000 title claims description 25
- 238000002255 vaccination Methods 0.000 title claims description 24
- 238000000034 method Methods 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 claims abstract 9
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 claims description 21
- 238000002649 immunization Methods 0.000 claims description 12
- 230000003053 immunization Effects 0.000 claims description 12
- 230000009385 viral infection Effects 0.000 claims description 8
- 241000204003 Mycoplasmatales Species 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 12
- 241000282898 Sus scrofa Species 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 230000003902 lesion Effects 0.000 description 6
- 208000023504 respiratory system disease Diseases 0.000 description 6
- 241000204031 Mycoplasma Species 0.000 description 5
- 238000007918 intramuscular administration Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000000585 Mann–Whitney U test Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 241000700198 Cavia Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 206010069767 H1N1 influenza Diseases 0.000 description 2
- 241001071864 Lethrinus laticaudis Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002941 microtiter virus yield reduction assay Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 201000010740 swine influenza Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 241000606750 Actinobacillus Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 206010021432 Immunisation reaction Diseases 0.000 description 1
- 241001148567 Lawsonia intracellularis Species 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010035724 Pneumonia mycoplasmal Diseases 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
- 241000711484 Transmissible gastroenteritis virus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 210000001132 alveolar macrophage Anatomy 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 244000309457 enveloped RNA virus Species 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000017924 poor diet Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79109406P | 2006-04-10 | 2006-04-10 | |
| EP06112444.2 | 2006-04-10 | ||
| EP06112444 | 2006-04-10 | ||
| US60/791094 | 2006-04-10 | ||
| PCT/EP2007/053420 WO2007116032A1 (en) | 2006-04-10 | 2007-04-06 | Vaccine against mycoplasma prrsv |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0710550A2 true BRPI0710550A2 (pt) | 2011-08-16 |
Family
ID=37114256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0710550-9A BRPI0710550A2 (pt) | 2006-04-10 | 2007-04-06 | uso de uma dose imunogênica de material imunogênico de mycoplasma hyopneumoniae e uma dose imunogênica de vìrus de prrs atenuado vivo, kit de vacina, e, método para a vacinação de porcos |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN101420975B (de) |
| AT (1) | ATE535253T1 (de) |
| BR (1) | BRPI0710550A2 (de) |
| DK (1) | DK2007419T3 (de) |
| ES (1) | ES2377576T3 (de) |
| RU (1) | RU2408386C2 (de) |
| UA (1) | UA93901C2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013526866A (ja) | 2010-05-19 | 2013-06-27 | バイオプロパティーズ ピーティーワイ リミテッド | 弱毒化マイコプラズマに関する方法 |
| UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
| UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
| CN104248759B (zh) * | 2013-11-19 | 2017-05-10 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其制备方法和应用 |
| EP3897710A1 (de) | 2018-12-20 | 2021-10-27 | Intervet International B.V. | Prime-boost-impfschema |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7018638B2 (en) * | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
| CN1942204A (zh) * | 2004-04-26 | 2007-04-04 | 株式会社中央疫苗研究所 | 用于猪呼吸病的灭活混合疫苗及其制备方法 |
-
2007
- 2007-04-06 AT AT07727888T patent/ATE535253T1/de active
- 2007-04-06 RU RU2008144180/15A patent/RU2408386C2/ru not_active IP Right Cessation
- 2007-04-06 ES ES07727888T patent/ES2377576T3/es active Active
- 2007-04-06 DK DK07727888.5T patent/DK2007419T3/da active
- 2007-04-06 UA UAA200812024A patent/UA93901C2/ru unknown
- 2007-04-06 BR BRPI0710550-9A patent/BRPI0710550A2/pt not_active Application Discontinuation
- 2007-04-06 CN CN2007800129701A patent/CN101420975B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE535253T1 (de) | 2011-12-15 |
| DK2007419T3 (da) | 2012-03-19 |
| UA93901C2 (ru) | 2011-03-25 |
| RU2008144180A (ru) | 2010-05-20 |
| RU2408386C2 (ru) | 2011-01-10 |
| CN101420975B (zh) | 2012-06-27 |
| ES2377576T3 (es) | 2012-03-29 |
| CN101420975A (zh) | 2009-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11738077B2 (en) | Immunogenic compositions comprising Lawsonia intracellularis | |
| US8021670B2 (en) | Vaccine against Mycoplasma PRRSV | |
| BR122015028489B1 (pt) | Vacina de combinação multivalente contra pcv2, bem como uso de uma proteína orf2 na preparação da mesma | |
| BR112014024785B1 (pt) | composições imunogênica multivalente e de vacina e seus uso para imunização contra mycoplasma hyopneumoniae e circovírus suíno tipo 2 e método de preparação, bem como kit compreendendo as ditas composições | |
| CN101420975B (zh) | 抗支原体和prrsv的疫苗 | |
| BR112019010394A2 (pt) | vacina suína | |
| BR112020017520A2 (pt) | Método para redução de escatol e/ou indol em animais | |
| AU2012207016B2 (en) | Immunogenic compositions comprising Lawsonia intracellularis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8 E13, 10, 25 DA LPI |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |